|
|
|
Volumn 64, Issue 6, 2001, Pages 1045-1054
|
|
Guideline for the management of heart failure caused by systolic dysfunction: Part II. Treatment
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALDOSTERONE ANTAGONIST;
AMIODARONE;
ANTACID AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
BISOPROLOL FUMARATE;
CAPTOPRIL;
CARVEDILOL;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL MALEATE;
ERYTHROMYCIN;
ETACRYNIC ACID;
FUROSEMIDE;
HYDROCHLOROTHIAZIDE;
LISINOPRIL;
LITHIUM;
METOPROLOL;
METOPROLOL TARTRATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
QUINIDINE;
QUININE;
RAMIPRIL;
SOTALOL;
SPIRONOLACTONE;
TORASEMIDE;
TRANDOLAPRIL;
UNINDEXED DRUG;
WARFARIN;
BLEEDING;
CLINICAL EXAMINATION;
DRUG COST;
DRUG METABOLISM;
HEART FAILURE;
HEART LEFT VENTRICLE FAILURE;
HEMOSTASIS;
HUMAN;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
REVIEW;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BLOOD PRESSURE;
CARDIOTONIC AGENTS;
DIET;
DIGOXIN;
DIURETICS;
EXERCISE;
HEART FAILURE, CONGESTIVE;
HUMANS;
PATIENT EDUCATION;
REFERRAL AND CONSULTATION;
SYSTOLE;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 0035883966
PISSN: 0002838X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (21)
|
|
References (34)
|
